Feb 7, 2023
PreciseDx Receives New York State Approval for an AI-Enabled Breast Diagnostic
See More
Feb 7, 2023
PreciseDx Receives New York State Approval for an AI-Enabled Breast Diagnostic
See More
Media Coverage
Feb 7, 2023
PreciseDx Receives New York State Approval for an AI-Enabled Breast Diagnostic
See More
Feb 7, 2023
PreciseDx Receives New York State Approval for an AI-Enabled Breast Diagnostic
See More
Media Coverage
Feb 7, 2023
New York State Department of Health approves PreciseDx breast cancer LDT
See More
Feb 7, 2023
New York State Department of Health approves PreciseDx breast cancer LDT
See More
Media Coverage
Feb 7, 2023
PreciseDx Receives New York State Approval For An AI-Enabled Breast Diagnostic
See More
Feb 7, 2023
PreciseDx Receives New York State Approval For An AI-Enabled Breast Diagnostic
See More
Media Coverage
Jan 31, 2023
Technology’s Role In Determining Cancer Treatment
See More
Jan 31, 2023
Technology’s Role In Determining Cancer Treatment
See More
Jan 31, 2023
PreciseDx Appoints Paul Roma as Chairman of the Board
See More
Jan 31, 2023
PreciseDx Appoints Paul Roma as Chairman of the Board
See More
Media Coverage
Jan 23, 2023
PreciseDx AI Platform Predicts Early-Stage Breast Cancer Recurrence
See More
Jan 23, 2023
PreciseDx AI Platform Predicts Early-Stage Breast Cancer Recurrence
See More
Media Coverage
Jan 23, 2023
PreciseDx Announces Publication in Breast Cancer Research that Validates Its AI-Enabled Platform
See More
Jan 23, 2023
PreciseDx Announces Publication in Breast Cancer Research that Validates Its AI-Enabled Platform
See More
Media Coverage
Jan 21, 2023
PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard
See More
Jan 21, 2023
PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard
See More
Jan 19, 2023
PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard
See More
Jan 19, 2023
PreciseDx Announces Publication in Breast Cancer Research; Validates Its AI-Enabled Platform that Predicts Early-Stage Breast Cancer Recurrence Better than Current Industry Standard
See More
No results.
Contact us today to learn more about PreciseBreast.
